Clinical Trials Browser

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

Clinical Trials

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules Combined With D-1553 Tablets in Subjects With Locally Advanced or Metastatic Solid Tumors With the KRASG12C Mutation

A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors

Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors

MPDL3280A-treatment-IST-UMCG

ASOTIAPWST

First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors

HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors

BC3195

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors

Study of AMV564 in Subjects With Advanced Solid Tumors

Study of CS3006 in Subjects With Locally Advanced or Metastatic Solid Tumors

Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors

A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)